News

Lions Bay Announces Definitive Agreement for BioVaxys Acquisition and Concurrent Financing

Lions Bay Announces Definitive Agreement for BioVaxys Acquisition and Concurrent Financing Vancouver, British Columbia–(Newsfile Corp. – June 4, 2020) – Lions Bay Mining Corp. (CSE: LBM) (the “Company” or “Lions Bay”) is pleased to announce that it has executed a Share Exchange Agreement (the “Definitive Agreement”) with BioVaxys Inc. (previously known as BioVaxys LLC) (“BioVaxys”), […]

Lions Bay Mining Announces Update on Acquisition Target BioVaxys Initiating A SARS-CoV-2 Vaccine Study

Vancouver, British Columbia–(Newsfile Corp. – May 14, 2020) – Lions Bay Mining Corp. (CSE: LBM) (the “Company” or “Lions Bay“) is pleased to announce that it has been informed that BioVaxys LLC ( “BioVaxys”) is in the process of preparing to launch a preclinical study of its proprietary vaccine for SARS-CoV-2, the virus that causes […]

Thomas Jefferson University and BioVaxys LLC enter into exclusive worldwide license

PHILADELPHIA–(BUSINESS WIRE)–Thomas Jefferson University, a Philadelphia-based professional university with a national reputation for transdisciplinary learning and innovation, and BioVaxys LLC, a privately-held, clinical stage biotechnology company, announced today that they have entered into an exclusive worldwide license agreement for a technology comprising highly-targeted, patient-specific, immunotherapeutic vaccines to treat ovarian cancer, melanoma, and other solid tumor […]